Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.295 USD | +4.44% | +11.21% | +45.55% |
05-07 | Top Premarket Gainers | MT |
05-06 | Transcript : FibroGen, Inc., Q1 2024 Earnings Call, May 06, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.55% | 123M | |
+33.44% | 50.85B | |
+0.79% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.93% | 26.11B | |
-21.66% | 19.13B | |
+9.20% | 13.05B | |
+27.06% | 12.16B | |
+23.96% | 12.08B |
- Stock Market
- Equities
- FGEN Stock
- News FibroGen, Inc.
- FibroGen : Goldman Sachs Adjusts Price Target on FibroGen to $22 From $24, Maintains Neutral Rating